Infectious Diseases Society of America (IDSA) Annual Me

Julie Parsonnet, MD, discussed well-established links between infectious disease and chronic disease and microorganisms disappearing from the human microbiome.

Julie Parsonnet, MD, argued that infectious disease plays a major role in causing chronic disease, but that links between them must be rigorously established.

HPV vaccination is routinely recommended for females but not males, though that may soon change-and cost-effectiveness may be an important argument in favor.

At the end of his lecture on the successes and challenges of vaccination, Larry Pickering, MD, showed a video illustrating its benefits. Check it out here.

Larry Pickering, MD, described some of the challenges that the US vaccination program faces going forward.

Larry Pickering, MD, described immunization as a great public health triumph and talked of how the US maintains high vaccination rates.

Four of five infectious disease specialists report having had to prescribe an alternative microbial agent due to drug shortages-with sometimes dire consequences.

A third study on the human microbiome found an antagonistic relationship between two fungi in HIV patients.

Kevin Ault, MD, of Emory University discusses arguments for and against HPV vaccination in males, with an emphasis on cost-effectiveness.

During "Improving HIV Care: Access, Reform, and the National AIDS Strategy" session, the three speakers discussed the importance of developing a national strategy, the impact of the Affordable Care Act, and the financial sense and burden of caring for people with HIV.

A second study on the human microbiome found significant changes in the oral microbiome of patients susceptible to health care acquired pneumonia.

A press conference highlighted exciting new studies on the human microbiome-including one suggesting that antibiotic use may be behind the obesity epidemic.

In this video, Joel Gallant, MD, lead author, board member at HIVMA, associate director at Johns Hopkins AIDS Service, discusses issues related to a policy paper recently released by the HIV Medicine Association.

Tom Tryon, MD, Associate Professor of Pediatrics at University of Missouri-Kansas City School of Medicine, evaluates pediatricians' approaches in dealing with parents who are hesitant to have their children immunized.

Dr. Omer briefly outlines the results from "Are younger doctors more skeptical of vaccines?"

Pioneering researcher Michael Saag, MD, finished his whirlwind tour of the history of HIV and AIDS and looked toward the future-and the end of AIDS.

Pioneering researcher Michael Saag, MD, gave a whirlwind tour of the history of HIV and AIDS at the conference's opening plenary session.

Initial results of a Phase 3 trial of the experimental malaria vaccine RTS,S found that it cut the risk of contracting malaria approximately in half.

Known as the "essential reference for infectious disease treatment," the Sanford Guide was awarded a contract with the US Department of Veteran Affairs to make its web edition available to all VA Medical Centers.

Loucq discusses initial results of a trial of the experimental malaria vaccine RTS,S in which risk of infection was cut in half.

A press conference highlighted a study on doctors' beliefs on vaccine safety and efficacy and one on pediatricians' experience of parental vaccine resistance.

Here is information about some of the topics that are being discussed at this year's IDSA Annual Meeting.

Data suggest respiratory infections in transplant patients are associated with increased long-term mortality and morbidity.

New measures assess patient retention, infection screening and prophylaxis, immunization, and initiation and monitoring of antiretroviral therapy.

Molecular respiratory viral diagnostics are rapidly becoming the new gold standard in respiratory viral detection.

What are the most effective prevention and treatment strategies for respiratory tract infections in transplant and other immunocompromised patients?

The increased life expectancy of patients with HIV has elevated the importance of the primary care physician in managing this patient population.

Studies show that even moderately effective rotavirus vaccines can save millions of lives annually.

Combination horizontal and vertical prevention efforts can reduce MRSA, VRE, MDR acinetobacter, and other nosocomial infections by 50%.

Although not as severe as feared, the 2009 H1N1 influenza pandemic provided valuable lessons with respect to special populations and treatment.